Pancreatic Cancer Research

ResearcherJilin UniversityActive in the last 2 years

Changfeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4497-0792; OpenAlex author ID A5102807899. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 2 papers

Papers 2

  1. CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. Co-author DOI 10.1038/s41467-025-57583-2↗
  2. AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adp4986↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiao Liu · 2 shared papers, 2025 · strength 0.55
  2. Fangquan Chen · 2 shared papers, 2025 · strength 0.55
  3. Rui Kang · 2 shared papers, 2025 · strength 0.55
  4. Daolin Tang · 2 shared papers, 2025 · strength 0.55
  5. Yuanda Liu · 1 shared paper, 2025 · strength 0.25
  6. Yangchun Xie · 1 shared paper, 2025 · strength 0.25
  7. Herbert J. Zeh · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.